Havana, May 17 (RHC-PL)-- Cuba has created a medicine that seeks to delay the progress of Alzheimer's, according to health officials in Havana. Researchers announced that the drug, called NeuroEpo, will undergo clinical trials for the first time in humans.
The specialists seek to delay the progress of Alzheimer's and in this way improve the quality of life of people suffering from this degenerative disease through a more effective treatment with NeuroEpo, a 100% Cuban product developed by the Center for Molecular Immunology (CIM).
The drug has been shown to have a neuro-protective effect during experimental phases. This would be the first time it will been tested in humans, so the exact results in each of the patients is not known, noted Leslie Perez, a CIM researcher.
Alzheimer's is a neuro-degenerative disease that has no cure, so the specialist emphasized that the goal of treatment "is to help delay that degenerative process and improve the quality of life of that person, and the family."
According to the prevalence rates of researchers in Cuba, there are approximately 160,000 people suffering from the disease and it is estimated that by 2040 these will increase 2.3 times reaching 2.7% of the total population of the island.
Cuba Creates Medicine to Counteract Alzheimer's
Rilataj Artikoloj
Komentarioj
Lasu komentarion
Ĉiuj kampoj bezonatasPliaj Vidaĵoj
- Raúl kaj Díaz-Canel prezidis la centran aranĝon por la 26-a de julio en Sancti Spíritus
- Rimarkinda venko de la kuba duopo kontraŭ favorita Brazilo en plaĝa flugopilko en Parizo-2024
- Tago de Esperanto 2024: Por mondo por ĉiuj lingvoj kaj sen lingva diskriminacio
- Tria plena sesio de la 20-a Centra Komitato de la Komunista Partio de Ĉinio
- Edukado en la programo de l´ Moncada